首页 > 最新文献

Recent patents on biotechnology最新文献

英文 中文
Plant Extracts and Phytochemicals, a Promising Strategy Against Oral Lichen Planus: A Review on Clinical Trials. 植物提取物和植物化学物质:一种治疗口腔扁平苔藓的有前景的策略:临床试验综述。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220718145421
Swati Gupta, Dr Lekshmi R Nath, Dr Sabitha M

Background: Oral lichen planus (OLP) is an autoimmune disease that distress keratinized cells of the oral epithelium. Topical corticosteroids and other potential therapies like immunosuppressives, hydroxychloroquine, azathioprine, mycophenolate, dapsone, retinoids, biologic agents are used for the management of OLP. However, their effectiveness, best dose, duration of treatment and safety remain mostly unidentified. Moreover, recurrence of disease and dose-related side effects are the other issues.

Objective: The primary objective of the review is to explore the existing clinical trials for the efficacy of phytochemicals in treating OLP in comparison to corticosteroids. A comprehensive information about their mode of action is also discussed.

Methods: We have discussed different clinical trials conducted on various phytochemicals and plant extracts/formulations like curcumin, lycopene, quercetin, glycyrrhizin, purslane, raspberry, aloe vera gel and aloe vera mouthwash for the treatment of OLP.

Results: The current therapy for the management of OLP has numerous adverse effects and requires a long-term treatment. Phytochemicals can be a very good alternative in overcoming these side effects and reducing the course of treatment.

Conclusion: Herbal extracts and their formulations can be an effective alternative to the current therapy due to their proven therapeutic effects, reduced side effects, long-term applicability, prevention of recurrence as well as progression into cancer.

背景:口腔扁平苔藓(OLP)是一种自身免疫性疾病,损害口腔上皮的角化细胞。局部皮质类固醇和其他潜在的治疗方法,如免疫抑制剂、羟氯喹、硫唑嘌呤、霉酚酸盐、氨苯砜、类维生素a、生物制剂等,被用于治疗OLP。然而,它们的有效性、最佳剂量、治疗持续时间和安全性大多尚未确定。此外,疾病复发和剂量相关的副作用是其他问题。目的:本综述的主要目的是探讨与皮质类固醇相比,植物化学物质治疗OLP疗效的现有临床试验。本文还讨论了它们的作用方式。方法:我们讨论了各种植物化学物质和植物提取物/配方,如姜黄素、番茄红素、槲皮素、甘草酸、马齿苋、覆盆子、芦荟凝胶和芦荟漱口水治疗OLP的不同临床试验。结果:目前治疗OLP的方法有许多不良反应,需要长期治疗。植物化学物质在克服这些副作用和缩短治疗过程方面是一个很好的选择。结论:中药提取物及其制剂具有疗效确切、副作用小、长期适用、预防复发和进展为癌症的特点,是目前治疗方法的有效替代。
{"title":"Plant Extracts and Phytochemicals, a Promising Strategy Against Oral Lichen Planus: A Review on Clinical Trials.","authors":"Swati Gupta,&nbsp;Dr Lekshmi R Nath,&nbsp;Dr Sabitha M","doi":"10.2174/1872208316666220718145421","DOIUrl":"https://doi.org/10.2174/1872208316666220718145421","url":null,"abstract":"<p><strong>Background: </strong>Oral lichen planus (OLP) is an autoimmune disease that distress keratinized cells of the oral epithelium. Topical corticosteroids and other potential therapies like immunosuppressives, hydroxychloroquine, azathioprine, mycophenolate, dapsone, retinoids, biologic agents are used for the management of OLP. However, their effectiveness, best dose, duration of treatment and safety remain mostly unidentified. Moreover, recurrence of disease and dose-related side effects are the other issues.</p><p><strong>Objective: </strong>The primary objective of the review is to explore the existing clinical trials for the efficacy of phytochemicals in treating OLP in comparison to corticosteroids. A comprehensive information about their mode of action is also discussed.</p><p><strong>Methods: </strong>We have discussed different clinical trials conducted on various phytochemicals and plant extracts/formulations like curcumin, lycopene, quercetin, glycyrrhizin, purslane, raspberry, aloe vera gel and aloe vera mouthwash for the treatment of OLP.</p><p><strong>Results: </strong>The current therapy for the management of OLP has numerous adverse effects and requires a long-term treatment. Phytochemicals can be a very good alternative in overcoming these side effects and reducing the course of treatment.</p><p><strong>Conclusion: </strong>Herbal extracts and their formulations can be an effective alternative to the current therapy due to their proven therapeutic effects, reduced side effects, long-term applicability, prevention of recurrence as well as progression into cancer.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 1","pages":"80-91"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10871339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of Captopril and BQ123 Endothelin-1 Antagonist on Experimentally Induced Hyperlipidemic Nephropathy in Rats. 卡托普利联合BQ123内皮素-1拮抗剂对实验性高脂血症大鼠肾病的影响。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220629150347
Jaiswal A, Semwal Bc, Singh S

Background: Kidney disease is a universal public health problem, and epidemiological studies demonstrated that the incidences of chronic kidney disease are increasing day by day. However, the efficiency of currently available drugs on the progression of nephropathy is limited. Therefore, the current research was designed to evaluate the therapeutic efficacy of captopril and BQ123 against hyperlipidemia-induced nephropathy in rats.

Objective: The objective of this study was to examine the implication of Endothelin-1 in experimentally induced hyperlipidemic nephropathy in rats.

Methods: Animals were divided into various groups, and the administration of a high-fat diet for six weeks induced hyperlipidemia. After confirmation of hyperlipidemia, treatment was started for the next 14 days. At the end of the experimental period, the animals were sacrificed, and various biochemical parameters and histopathological studies were performed.

Results: Treatment of both the agents in combination effectively decreased BUN levels, serum creatinine, serum nitrite, and proinflammatory markers and ameliorated the pathological injuries to kidneys.

Conclusion: Furthermore, both treatments also inhibited oxidative stress and restored the hyperlipidemia-induced reduction in the level of antioxidant enzymes.

背景:肾脏疾病是一个普遍的公共卫生问题,流行病学研究表明慢性肾脏疾病的发病率日益增加。然而,目前可用的药物对肾病进展的有效性是有限的。因此,本研究旨在评价卡托普利和BQ123对大鼠高脂血症肾病的治疗效果。目的:探讨内皮素-1在实验性高脂血症大鼠中的作用。方法:将实验动物分为不同的组,给予高脂饮食6周诱导高脂血症。确诊为高脂血症后,开始治疗14天。实验结束时,处死动物,进行各项生化参数和组织病理学检查。结果:两种药物联合治疗可有效降低BUN水平、血清肌酐、血清亚硝酸盐及促炎指标,改善肾脏病理损伤。结论:两种处理均能抑制氧化应激,恢复高脂血症引起的抗氧化酶水平下降。
{"title":"Effect of Captopril and BQ123 Endothelin-1 Antagonist on Experimentally Induced Hyperlipidemic Nephropathy in Rats.","authors":"Jaiswal A,&nbsp;Semwal Bc,&nbsp;Singh S","doi":"10.2174/1872208316666220629150347","DOIUrl":"https://doi.org/10.2174/1872208316666220629150347","url":null,"abstract":"<p><strong>Background: </strong>Kidney disease is a universal public health problem, and epidemiological studies demonstrated that the incidences of chronic kidney disease are increasing day by day. However, the efficiency of currently available drugs on the progression of nephropathy is limited. Therefore, the current research was designed to evaluate the therapeutic efficacy of captopril and BQ123 against hyperlipidemia-induced nephropathy in rats.</p><p><strong>Objective: </strong>The objective of this study was to examine the implication of Endothelin-1 in experimentally induced hyperlipidemic nephropathy in rats.</p><p><strong>Methods: </strong>Animals were divided into various groups, and the administration of a high-fat diet for six weeks induced hyperlipidemia. After confirmation of hyperlipidemia, treatment was started for the next 14 days. At the end of the experimental period, the animals were sacrificed, and various biochemical parameters and histopathological studies were performed.</p><p><strong>Results: </strong>Treatment of both the agents in combination effectively decreased BUN levels, serum creatinine, serum nitrite, and proinflammatory markers and ameliorated the pathological injuries to kidneys.</p><p><strong>Conclusion: </strong>Furthermore, both treatments also inhibited oxidative stress and restored the hyperlipidemia-induced reduction in the level of antioxidant enzymes.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 2","pages":"151-162"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9833988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antidiabetic Agents from Fungi with Special Reference to α-Glucosidase Inhibitors. 真菌抗糖尿病药物,特别是α-葡萄糖苷酶抑制剂。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220512122439
Sunil Kumar Deshmukh, Manish Kumar Gupta, Shivankar Agrawal

The enzyme α-glucosidases (EC 3.2.1.20) catalyzes the hydrolysis of α-1,4- glucopyranoside bond in oligosaccharides and disaccharides, and thus plays an essential role in regulating glucose content and the level of postprandial hyperglycemia. The inhibition of α-glucosidases is considered a viable strategy to develop new and effective antidiabetic drugs. Many patents like ZA201905405B; US9073897B2 have been published on α- glucosidase inhibitors. In recent years, several classes of fungal metabolites possessing a varying degree of α-glucosidases inhibitory activity have been reported. The primary chemical classes include xanthone, phenanthrene, terpenoid, coumarin, isocoumarin, naphthalene, piperazine, and polyketides. Few of the identified inhibitors exhibited severalfold better activities than well-known α-glucosidases inhibitor acarbose and can be used as a lead to develop new antidiabetic drugs. The present review highlights the recent development in the identification of α-glucosidases inhibitors from various fungal sources. Their chemical class, structures, and inhibitory activity in terms of IC50 or MIC are discussed here.

α-葡萄糖苷酶(EC 3.2.1.20)催化水解低聚糖和双糖中的α-1,4-葡萄糖苷键,在调节葡萄糖含量和餐后高血糖水平中起重要作用。抑制α-葡萄糖苷酶被认为是开发新型有效降糖药的可行策略。ZA201905405B等多项专利;US9073897B2已发表的α-葡萄糖苷酶抑制剂。近年来,已经报道了几种具有不同程度α-葡萄糖苷酶抑制活性的真菌代谢物。主要的化学类包括山酮、菲、萜类、香豆素、异香豆素、萘、哌嗪和聚酮。所鉴定的几种抑制剂的活性比已知的α-葡萄糖苷酶抑制剂阿卡波糖好几倍,可以作为开发新型降糖药的先导。本文综述了从不同真菌源中鉴定α-葡萄糖苷酶抑制剂的最新进展。本文讨论了它们的化学类别、结构和IC50或MIC的抑制活性。
{"title":"Antidiabetic Agents from Fungi with Special Reference to α-Glucosidase Inhibitors.","authors":"Sunil Kumar Deshmukh,&nbsp;Manish Kumar Gupta,&nbsp;Shivankar Agrawal","doi":"10.2174/1872208316666220512122439","DOIUrl":"https://doi.org/10.2174/1872208316666220512122439","url":null,"abstract":"<p><p>The enzyme α-glucosidases (EC 3.2.1.20) catalyzes the hydrolysis of α-1,4- glucopyranoside bond in oligosaccharides and disaccharides, and thus plays an essential role in regulating glucose content and the level of postprandial hyperglycemia. The inhibition of α-glucosidases is considered a viable strategy to develop new and effective antidiabetic drugs. Many patents like ZA201905405B; US9073897B2 have been published on α- glucosidase inhibitors. In recent years, several classes of fungal metabolites possessing a varying degree of α-glucosidases inhibitory activity have been reported. The primary chemical classes include xanthone, phenanthrene, terpenoid, coumarin, isocoumarin, naphthalene, piperazine, and polyketides. Few of the identified inhibitors exhibited severalfold better activities than well-known α-glucosidases inhibitor acarbose and can be used as a lead to develop new antidiabetic drugs. The present review highlights the recent development in the identification of α-glucosidases inhibitors from various fungal sources. Their chemical class, structures, and inhibitory activity in terms of IC<sub>50</sub> or MIC are discussed here.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 1","pages":"24-61"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10872040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Recent Patents on the Industrial Application of Biosurfactants. 生物表面活性剂工业应用新专利。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208317666230117143535
Maria Auxiliadora de Oliveira, Felipe Ferreira Silva, Vinícius Souza Tarabal, Diego Fernandes Livio, Hiure Gomes Ramos Meira, Pablo Felipe Rodrigues Gonçalves, Adriano Guimarães Parreira, José Antonio da Silva, Daniel Bonoto Gonçalves, Paulo Afonso Granjeiro

Background: Biosurfactants are natural bioactive compounds produced from fungi, bacteria and plants. These molecules have several properties that enable them to be involved in various industrial applications. The surface-active properties of biosurfactants allow their use in various sectors, such as agriculture, health, cosmetics, bioremediation/ petroleum, mining, and bioprocess.

Objective: The objective of this study was to analyze the patents deposited in intellectual property databases for applications of biosurfactants in the areas of agriculture, health, cosmetics, bioremediation/petroleum, mining, and bioprocesses, with the research period consisting of the last six years.

Methods: This study targeted the use of biosurfactants in various industrial sectors. The patent search was carried out using the Google Patents platform, a platform that is commonly used for this purpose and freely accessible.

Results: During the search for patents related to applications of biosurfactants in industry filed in the last 6 years, results were found to be distributed in the following areas: agriculture (70), cosmetics (2311), bioremediation/petroleum (179), health (1794), mining (5), and bioprocess (133). Six patents were selected from each area, except for health and mining, for which the search resulted in only 5 and 4 patents, respectively, to be discussed and provide information on the biotechnological applications of biosurfactants in the industry.

Conclusion: The present study showed a wide area of application of biosurfactants in industry. The interest in the inclusion of biosurfactants in the industry is directly related to the need for more sustainable solutions to solve real market problems. The cosmetics sector presented the most patents that employ the use of biosurfactants.

背景:生物表面活性剂是从真菌、细菌和植物中产生的天然生物活性化合物。这些分子具有一些特性,使它们能够参与各种工业应用。生物表面活性剂的表面活性特性使其可用于各种领域,如农业、卫生、化妆品、生物修复/石油、采矿和生物工艺。目的:本研究的目的是分析知识产权数据库中关于生物表面活性剂在农业、卫生、化妆品、生物修复/石油、采矿和生物工艺等领域应用的专利,研究时间为近6年。方法:针对生物表面活性剂在不同工业领域的应用进行研究。专利检索是使用谷歌专利平台进行的,该平台通常用于此目的,并且可以免费访问。结果:通过对近6年生物表面活性剂在工业领域应用专利的检索,发现结果分布在以下领域:农业(70)、化妆品(2311)、生物修复/石油(179)、卫生(1794)、采矿(5)和生物工艺(133)。除卫生和采矿领域外,每个领域都选择了6项专利,对这两项专利的检索结果分别只有5项和4项专利可供讨论,并提供了关于生物表面活性剂在工业中的生物技术应用的信息。结论:生物表面活性剂具有广泛的工业应用前景。将生物表面活性剂纳入该行业的兴趣与需要更可持续的解决方案来解决实际市场问题直接相关。化妆品领域提交的使用生物表面活性剂的专利最多。
{"title":"Recent Patents on the Industrial Application of Biosurfactants.","authors":"Maria Auxiliadora de Oliveira,&nbsp;Felipe Ferreira Silva,&nbsp;Vinícius Souza Tarabal,&nbsp;Diego Fernandes Livio,&nbsp;Hiure Gomes Ramos Meira,&nbsp;Pablo Felipe Rodrigues Gonçalves,&nbsp;Adriano Guimarães Parreira,&nbsp;José Antonio da Silva,&nbsp;Daniel Bonoto Gonçalves,&nbsp;Paulo Afonso Granjeiro","doi":"10.2174/1872208317666230117143535","DOIUrl":"https://doi.org/10.2174/1872208317666230117143535","url":null,"abstract":"<p><strong>Background: </strong>Biosurfactants are natural bioactive compounds produced from fungi, bacteria and plants. These molecules have several properties that enable them to be involved in various industrial applications. The surface-active properties of biosurfactants allow their use in various sectors, such as agriculture, health, cosmetics, bioremediation/ petroleum, mining, and bioprocess.</p><p><strong>Objective: </strong>The objective of this study was to analyze the patents deposited in intellectual property databases for applications of biosurfactants in the areas of agriculture, health, cosmetics, bioremediation/petroleum, mining, and bioprocesses, with the research period consisting of the last six years.</p><p><strong>Methods: </strong>This study targeted the use of biosurfactants in various industrial sectors. The patent search was carried out using the Google Patents platform, a platform that is commonly used for this purpose and freely accessible.</p><p><strong>Results: </strong>During the search for patents related to applications of biosurfactants in industry filed in the last 6 years, results were found to be distributed in the following areas: agriculture (70), cosmetics (2311), bioremediation/petroleum (179), health (1794), mining (5), and bioprocess (133). Six patents were selected from each area, except for health and mining, for which the search resulted in only 5 and 4 patents, respectively, to be discussed and provide information on the biotechnological applications of biosurfactants in the industry.</p><p><strong>Conclusion: </strong>The present study showed a wide area of application of biosurfactants in industry. The interest in the inclusion of biosurfactants in the industry is directly related to the need for more sustainable solutions to solve real market problems. The cosmetics sector presented the most patents that employ the use of biosurfactants.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 4","pages":"376-394"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9527706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technological and Scientific Prospection on Pigments Produced by Microorganisms. 微生物生产色素的技术与科学展望。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208317666221101121410
Tainã Lima Silva de Souza, Carolina Oliveira de Souza, Marcelo Andrés Umsza-Guez

Background: Interest in natural pigments has grown due to the negative aspects caused by synthetic options, which trigger damage to the body and the environment. Research with natural pigments produced by microorganisms becomes viable in relation to other pigments extracted from animals or plants, as microorganisms have advantages in terms of versatility and productivity. Thus, production technologies are protected by patents.

Methods: To evaluate the evolution of research and technological development on producing natural pigments by different microorganisms through scientific and technological prospection. Scientific prospecting was done by searching articles published from 2010 to 2020 in the Scopus, Science Direct, and Web of Science databases. Technological prospecting was carried out with patents obtained from the European Patent Office (ESPACENET) database.

Results: The searches were based on the keywords "pigment" and "dye" crossed with microalgae, fungi, bacteria and yeast. A total of 2.811 articles and 451 patents were selected. Scientific prospecting has shown interest in alternative cultivation media, and among the microorganisms that produce pigments, fungi and microalgae are the most studied.

Conclusion: Technological prospecting showed that 375 (83%) recovered patent documents refer to the protection of pigment extraction and production techniques and that the largest patent holders are private companies, followed by Chinese universities.

背景:由于合成色素会对人体和环境造成损害,人们对天然色素的兴趣越来越大。与从动物或植物中提取的其他色素相比,微生物生产的天然色素的研究变得可行,因为微生物在多功能性和生产力方面具有优势。因此,生产技术受到专利的保护。方法:通过科技展望,对不同微生物生产天然色素的研究进展和技术发展进行评价。通过检索Scopus、Science Direct和Web of Science数据库中2010年至2020年发表的文章进行科学勘探。利用从欧洲专利局(ESPACENET)数据库获得的专利进行技术勘探。结果:关键词“色素”和“染料”与微藻、真菌、细菌和酵母交叉搜索。共入选论文2811篇,专利451项。科学勘探对替代培养基表现出兴趣,在产生色素的微生物中,真菌和微藻是研究最多的。结论:技术调查结果显示,375件(83%)回收的专利文献涉及色素提取和生产技术的保护,专利持有人以私营企业居多,其次是中国高校。
{"title":"Technological and Scientific Prospection on Pigments Produced by Microorganisms.","authors":"Tainã Lima Silva de Souza,&nbsp;Carolina Oliveira de Souza,&nbsp;Marcelo Andrés Umsza-Guez","doi":"10.2174/1872208317666221101121410","DOIUrl":"https://doi.org/10.2174/1872208317666221101121410","url":null,"abstract":"<p><strong>Background: </strong>Interest in natural pigments has grown due to the negative aspects caused by synthetic options, which trigger damage to the body and the environment. Research with natural pigments produced by microorganisms becomes viable in relation to other pigments extracted from animals or plants, as microorganisms have advantages in terms of versatility and productivity. Thus, production technologies are protected by patents.</p><p><strong>Methods: </strong>To evaluate the evolution of research and technological development on producing natural pigments by different microorganisms through scientific and technological prospection. Scientific prospecting was done by searching articles published from 2010 to 2020 in the Scopus, Science Direct, and Web of Science databases. Technological prospecting was carried out with patents obtained from the European Patent Office (ESPACENET) database.</p><p><strong>Results: </strong>The searches were based on the keywords \"pigment\" and \"dye\" crossed with microalgae, fungi, bacteria and yeast. A total of 2.811 articles and 451 patents were selected. Scientific prospecting has shown interest in alternative cultivation media, and among the microorganisms that produce pigments, fungi and microalgae are the most studied.</p><p><strong>Conclusion: </strong>Technological prospecting showed that 375 (83%) recovered patent documents refer to the protection of pigment extraction and production techniques and that the largest patent holders are private companies, followed by Chinese universities.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 4","pages":"364-375"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9580767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physicochemical Properties and Biological Activities of Koseret (Lippia adoensis Hochst. Var. Koseret) Seed and Leaf Oil Extracts. 香菜(Lippia adoensis Hochst)理化性质及生物活性。种子和叶油提取物。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220617104318
Mekdes Shiferaw, Zekeria Yusuf, Mulugeta Desta

Background: Lippia adoensis Hoechst var. adoensis (wild variety) and variety koseret (cultivated variety) have been used as traditional medicine, condiments, and endemic to Ethiopia.

Objective: This study aimed to assess the physicochemical properties and biological activities of oil extracts from seed and leaves of koseret (L. adoensis var. koseret).

Methodology: Soxhlet apparatus was used for oil extraction using hexane as a solvent. The oil quality assessment was based on oil yield, acid value, percent free fatty acid, and peroxide value, while the biological activities were investigated based on antioxidant and antimicrobial activities. The antimicrobial experiment was arranged as 2 x1x4 in a completely randomized factorial design with three replications.

Results: The result indicated that significantly higher oil yield (2.25%), acid value (2.66%) and free fatty acid (1.34%) were recorded for seed oil using the solvent extraction method. Leaf oil was recorded to have significantly higher values of DPPH (2,2- diphenyl-1- picrylhydrazyl), ascorbic acid and total carotenoid contents, but a lower value of hydrogen peroxide scavenging activity indicated that leaf oil presented higher antioxidant activity than seed oil in koseret. The koseret leaf oil demonstrated stronger antibacterial activity with a maximum zone of inhibition (14.50±0.21 mm), minimum inhibitory concentration (MIC, 0.25 μg/ml) and corresponding minimum bactericidal concentration (MBC, 0.25 μg/ml) against S. aureus. Furthermore, leaf oil has also presented stronger antifungal activity with a maximum zone of inhibition (14.83 mm), MIC (0.25 μg/ml), and minimum fungicidal concentration (MFC, 0.50 μg/ml) against Aspergillus versicolor.

Conclusion: It can be concluded from the results of this study that leaf oil extract has demonstrated better biological activities, including both antioxidant and antimicrobial potentials, than seed oil in koseret.

背景:Lippia adoensis Hoechst var. adoensis(野生品种)和koseret(栽培品种)已被用作传统药物,调味品和埃塞俄比亚特有品种。目的:研究香菜种子和叶油提取物的理化性质及生物活性。方法:采用索氏萃取法,以己烷为溶剂进行萃取。以出油率、酸值、游离脂肪酸百分比和过氧化值评价油品质量,以抗氧化和抗菌活性研究生物活性。抗菌试验采用2 × 1 × 4全随机因子设计,3个重复。结果:溶剂萃取法提取的种子油得率(2.25%)、酸值(2.66%)和游离脂肪酸(1.34%)均显著提高。叶油的DPPH(2,2-二苯基-1-苦酰肼)、抗坏血酸和类胡萝卜素含量显著高于籽油,但过氧化氢清除活性较低,表明叶油的抗氧化活性高于籽油。芫荽叶油对金黄色葡萄球菌的最大抑制区(14.50±0.21 mm)、最小抑制浓度(MIC, 0.25 μg/ml)和相应的最小杀菌浓度(MBC, 0.25 μg/ml)均表现出较强的抑菌活性。此外,叶精油还具有较强的抗真菌活性,最大抑制区(14.83 mm), MIC (0.25 μg/ml),最小杀真菌浓度(MFC, 0.50 μg/ml)。结论:芫荽叶油提取物具有较好的抗氧化和抑菌活性。
{"title":"Physicochemical Properties and Biological Activities of Koseret (<i>Lippia adoensis</i> Hochst. Var. Koseret) Seed and Leaf Oil Extracts.","authors":"Mekdes Shiferaw,&nbsp;Zekeria Yusuf,&nbsp;Mulugeta Desta","doi":"10.2174/1872208316666220617104318","DOIUrl":"https://doi.org/10.2174/1872208316666220617104318","url":null,"abstract":"<p><strong>Background: </strong>Lippia adoensis Hoechst var. adoensis (wild variety) and variety koseret (cultivated variety) have been used as traditional medicine, condiments, and endemic to Ethiopia.</p><p><strong>Objective: </strong>This study aimed to assess the physicochemical properties and biological activities of oil extracts from seed and leaves of koseret (L. adoensis var. koseret).</p><p><strong>Methodology: </strong>Soxhlet apparatus was used for oil extraction using hexane as a solvent. The oil quality assessment was based on oil yield, acid value, percent free fatty acid, and peroxide value, while the biological activities were investigated based on antioxidant and antimicrobial activities. The antimicrobial experiment was arranged as 2 x1x4 in a completely randomized factorial design with three replications.</p><p><strong>Results: </strong>The result indicated that significantly higher oil yield (2.25%), acid value (2.66%) and free fatty acid (1.34%) were recorded for seed oil using the solvent extraction method. Leaf oil was recorded to have significantly higher values of DPPH (2,2- diphenyl-1- picrylhydrazyl), ascorbic acid and total carotenoid contents, but a lower value of hydrogen peroxide scavenging activity indicated that leaf oil presented higher antioxidant activity than seed oil in koseret. The koseret leaf oil demonstrated stronger antibacterial activity with a maximum zone of inhibition (14.50±0.21 mm), minimum inhibitory concentration (MIC, 0.25 μg/ml) and corresponding minimum bactericidal concentration (MBC, 0.25 μg/ml) against S. aureus. Furthermore, leaf oil has also presented stronger antifungal activity with a maximum zone of inhibition (14.83 mm), MIC (0.25 μg/ml), and minimum fungicidal concentration (MFC, 0.50 μg/ml) against Aspergillus versicolor.</p><p><strong>Conclusion: </strong>It can be concluded from the results of this study that leaf oil extract has demonstrated better biological activities, including both antioxidant and antimicrobial potentials, than seed oil in koseret.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 2","pages":"142-150"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9463505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the Cytotoxicity of Monolayered and Multilayered Carbon Nanotubes on Three Different Human Cell Lines. 评价单层和多层碳纳米管对三种不同人类细胞系的细胞毒性。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220820121657
Anahita Marhounian Nezhad, Omid Farshad, Mohammad Hossein Morowvat

Background: Nanotechnology and nanobiotechnology have emerged as novel technologies for the production and application of nanoscale materials in different pharmaceutical, medical, and biological fields. Besides, there are a bunch of recently published patents in this field. Although Carbon Nanotubes (CNTs) have various advantages and can be applied for a wide variety of purposes, their toxicity on humans is a matter of concern.

Objective: This study aimed to evaluate six different types of CNTs, including pristine, carboxylated, and hydroxylated single-walled CNTs (SWCNTs) and multi-walled CNTs (MWCNTs) on three human cell lines.

Methods: MTT assay was employed to assess the cytotoxicity of six types of CNTs, including pristine, carboxylated, and hydroxylated forms of SWCNTs and MWCNTs on three different human cell lines.

Results: The findings of the MTT assay showed that the six different types of CNTs (100- 600 μg/mL) exhibited different levels of cytotoxicity on the three human cell lines. The observed trend presented dose-dependent cytotoxicity on the three studied cell lines, including pulmonary, skin, and gastrointestinal cell lines. SWCNT-COOH and MWCNTs accounted for the lowest cell viability in the three human cell lines.

Conclusion: In conclusion, researchers and industrial workers are recommended to be cautious while working with different types of CNT because all their toxicity dimensions have not been determined yet.

背景:纳米技术和纳米生物技术已经成为纳米材料在不同制药、医学和生物领域的生产和应用的新技术。此外,最近在该领域有一堆专利。尽管碳纳米管(CNTs)具有多种优点,并可广泛应用于各种用途,但其对人体的毒性是一个令人关注的问题。目的:本研究旨在评估三种人类细胞系上的六种不同类型的碳纳米管,包括原始、羧化和羟基化单壁碳纳米管(SWCNTs)和多壁碳纳米管(MWCNTs)。方法:采用MTT法评估六种碳纳米管(包括原始、羧化和羟基化形式的SWCNTs和MWCNTs)对三种不同人类细胞系的细胞毒性。结果:MTT实验结果显示,6种不同类型的CNTs (100- 600 μg/mL)对3种人类细胞系表现出不同程度的细胞毒性。观察到的趋势呈现剂量依赖性细胞毒性对三种研究细胞系,包括肺,皮肤和胃肠道细胞系。在三种人类细胞系中,swcnts - cooh和MWCNTs的细胞活力最低。结论:总之,建议研究人员和产业工人在使用不同类型的碳纳米管时要谨慎,因为它们的所有毒性尺寸尚未确定。
{"title":"Evaluating the Cytotoxicity of Monolayered and Multilayered Carbon Nanotubes on Three Different Human Cell Lines.","authors":"Anahita Marhounian Nezhad,&nbsp;Omid Farshad,&nbsp;Mohammad Hossein Morowvat","doi":"10.2174/1872208316666220820121657","DOIUrl":"https://doi.org/10.2174/1872208316666220820121657","url":null,"abstract":"<p><strong>Background: </strong>Nanotechnology and nanobiotechnology have emerged as novel technologies for the production and application of nanoscale materials in different pharmaceutical, medical, and biological fields. Besides, there are a bunch of recently published patents in this field. Although Carbon Nanotubes (CNTs) have various advantages and can be applied for a wide variety of purposes, their toxicity on humans is a matter of concern.</p><p><strong>Objective: </strong>This study aimed to evaluate six different types of CNTs, including pristine, carboxylated, and hydroxylated single-walled CNTs (SWCNTs) and multi-walled CNTs (MWCNTs) on three human cell lines.</p><p><strong>Methods: </strong>MTT assay was employed to assess the cytotoxicity of six types of CNTs, including pristine, carboxylated, and hydroxylated forms of SWCNTs and MWCNTs on three different human cell lines.</p><p><strong>Results: </strong>The findings of the MTT assay showed that the six different types of CNTs (100- 600 μg/mL) exhibited different levels of cytotoxicity on the three human cell lines. The observed trend presented dose-dependent cytotoxicity on the three studied cell lines, including pulmonary, skin, and gastrointestinal cell lines. SWCNT-COOH and MWCNTs accounted for the lowest cell viability in the three human cell lines.</p><p><strong>Conclusion: </strong>In conclusion, researchers and industrial workers are recommended to be cautious while working with different types of CNT because all their toxicity dimensions have not been determined yet.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 2","pages":"186-195"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9468769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Biotechnological Review on Patents Applied to Rubella Diagnosis. 风疹诊断应用专利生物技术综述
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220902094706
Jonatas Oliveira da Silva, Michelli Dos Santos, Ana Amélia Maia Silva, André Vinícius Fernandes Ferreira, Laís Moreira Nogueira, Isadora Braga Gandra, Silvio José Elisei Carvalho Junior, Juliana Martins Machado, Ana Alice Maia Gonçalves, Rodolfo Cordeiro Giunchetti, Mariana Campos-da-Paz, Alexsandro Sobreira Galdino

Background: Rubella, caused by the Rubella virus (RV), is considered a mild self-limited illness. However, RV has teratogenic potential. Laboratory investigation plays an important role in both diagnosis and surveillance of the disease. The main methods for diagnosing Rubella are serological assays for the detection of specific IgM and molecular assays for detecting viral RNA. However, some laboratories perform IgG avidity testing, virus isolation and analysis of genetic sequence as tools to help Rubella eradication. The importance of the diagnosis of Rubella involves the appropriate treatment of the disease, because the Rubella clinical symptoms may be similar to those of other diseases, and the population monitoring to avoid new emergent cases. This study addresses different methods of diagnosing Rubella and contributes as a source of knowledge to assist health systems in controlling the disease.

Objective: The main objective of this study was to review the available patents regarding Rubella diagnosis published in intellectual property databases, and provides an overview of the technologies available for the diagnosis of Rubella.

Method: The search strategy was based on the keywords searched separately or together using a Boolean operator either in the patent title or abstract the time interval was restricted to patents filed or granted from January 2009 until February 2022. The database used was Google Patents.

Results: This study analyzed 24 patent documents regarding strategies for the diagnosis of Rubella. Of these, 15 patents disclose strategies for detecting Rubella antibodies, 7 patents the detection of Rubella virus nucleic acid, and 2 patents the production of antibodies applied in Rubella diagnosis.

Conclusion: Rubella is still a public health problem in some countries, mainly those in development, especially due to congenital Rubella syndrome, which can cause malformation or fetal death. However, its diagnosis is challenging, due to similarity of symptoms with other diseases, and for this reason, laboratory diagnosis is essential. Studies like this encourage researchers and governments to invest in research to continue the development of new products, using different areas of biotechnology, to solve society's problems, especially diseases that have an impact on global health, such as Rubella.

背景:由风疹病毒(RV)引起的风疹被认为是一种轻度自限性疾病。然而,RV具有致畸潜能。实验室调查在该病的诊断和监测中都起着重要作用。诊断风疹的主要方法是检测特异性IgM的血清学试验和检测病毒RNA的分子试验。然而,一些实验室将IgG亲和力检测、病毒分离和基因序列分析作为帮助根除风疹的工具。由于风疹的临床症状可能与其他疾病相似,因此诊断风疹的重要性在于适当治疗该病,并对人群进行监测以避免出现新的紧急病例。这项研究涉及诊断风疹的不同方法,并作为知识来源有助于卫生系统控制该疾病。目的:本研究的主要目的是回顾在知识产权数据库中公布的有关风疹诊断的现有专利,并对风疹诊断的现有技术进行概述。方法:采用布尔运算符在专利标题或摘要中单独或一起搜索关键词的检索策略,时间间隔限于2009年1月至2022年2月期间申请或授权的专利。使用的数据库是Google Patents。结果:本研究分析了24项关于风疹诊断策略的专利文献。其中,15项专利公开了风疹抗体的检测策略,7项专利公开了风疹病毒核酸的检测,2项专利公开了用于风疹诊断的抗体的生产。结论:风疹在一些国家仍然是一个公共卫生问题,主要是在发展中国家,特别是由于先天性风疹综合征,可导致畸形或胎儿死亡。然而,由于其症状与其他疾病相似,其诊断具有挑战性,因此实验室诊断至关重要。这样的研究鼓励研究人员和政府投资研究,继续开发新产品,利用生物技术的不同领域,解决社会问题,特别是对全球健康有影响的疾病,如风疹。
{"title":"A Biotechnological Review on Patents Applied to Rubella Diagnosis.","authors":"Jonatas Oliveira da Silva,&nbsp;Michelli Dos Santos,&nbsp;Ana Amélia Maia Silva,&nbsp;André Vinícius Fernandes Ferreira,&nbsp;Laís Moreira Nogueira,&nbsp;Isadora Braga Gandra,&nbsp;Silvio José Elisei Carvalho Junior,&nbsp;Juliana Martins Machado,&nbsp;Ana Alice Maia Gonçalves,&nbsp;Rodolfo Cordeiro Giunchetti,&nbsp;Mariana Campos-da-Paz,&nbsp;Alexsandro Sobreira Galdino","doi":"10.2174/1872208316666220902094706","DOIUrl":"https://doi.org/10.2174/1872208316666220902094706","url":null,"abstract":"<p><strong>Background: </strong>Rubella, caused by the Rubella virus (RV), is considered a mild self-limited illness. However, RV has teratogenic potential. Laboratory investigation plays an important role in both diagnosis and surveillance of the disease. The main methods for diagnosing Rubella are serological assays for the detection of specific IgM and molecular assays for detecting viral RNA. However, some laboratories perform IgG avidity testing, virus isolation and analysis of genetic sequence as tools to help Rubella eradication. The importance of the diagnosis of Rubella involves the appropriate treatment of the disease, because the Rubella clinical symptoms may be similar to those of other diseases, and the population monitoring to avoid new emergent cases. This study addresses different methods of diagnosing Rubella and contributes as a source of knowledge to assist health systems in controlling the disease.</p><p><strong>Objective: </strong>The main objective of this study was to review the available patents regarding Rubella diagnosis published in intellectual property databases, and provides an overview of the technologies available for the diagnosis of Rubella.</p><p><strong>Method: </strong>The search strategy was based on the keywords searched separately or together using a Boolean operator either in the patent title or abstract the time interval was restricted to patents filed or granted from January 2009 until February 2022. The database used was Google Patents.</p><p><strong>Results: </strong>This study analyzed 24 patent documents regarding strategies for the diagnosis of Rubella. Of these, 15 patents disclose strategies for detecting Rubella antibodies, 7 patents the detection of Rubella virus nucleic acid, and 2 patents the production of antibodies applied in Rubella diagnosis.</p><p><strong>Conclusion: </strong>Rubella is still a public health problem in some countries, mainly those in development, especially due to congenital Rubella syndrome, which can cause malformation or fetal death. However, its diagnosis is challenging, due to similarity of symptoms with other diseases, and for this reason, laboratory diagnosis is essential. Studies like this encourage researchers and governments to invest in research to continue the development of new products, using different areas of biotechnology, to solve society's problems, especially diseases that have an impact on global health, such as Rubella.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 4","pages":"332-345"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10063982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethnomedical Applications and Conservation Status of Leguminosae- Caesalpinioideae Plants in Uttar Pradesh, India. 印度北方邦豆科植物的民族医学应用及保护现状。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220622230215
Shivaraman Pandey, Lav Singh, Ravi Prakash Srivastava, Arun Kumar Kushwaha, Pooja Dixit, Gauri Saxena, Lal Babu Chaudhary

Background: This review highlights the folklore, ethnomedicinal uses and conservation status of Caesalpinioideae in Uttar Pradesh (India).

Aims: It aims at compiling available data on traditional medicine, biological activity, phytochemical information and assessing the regional red list status of Caesalpinioideae in Uttar Pradesh. The information provided would help in formulating new drugs and medicines and addressing global conservation issues of such medicinally exploited species.

Methods: The current study included an extensive and systematic review of available literature, the study of previous collections of herbarium specimens, random interviews with locals and tribals, field surveys, and GeoCAT tool-based assessment during 2016-2020. The study reports that the majority of species of Caesalpinioideae are used for curing digestive problems (about 20 species) and skin diseases (19 species).

Results: Almost all the species have antimicrobial and antioxidant properties. These pharmacological activities can be attributed to the presence of various types of anthraquinones in plants.

Conclusion: The regional conservation status reveals that eight species qualified for the status of regionally threatened category while two species fall under the near threatened category.

背景:本文综述了印度北方邦(Uttar Pradesh) Caesalpinioideae的民间传说、民族医学用途和保护现状。目的:它的目的是汇编关于传统医学、生物活性、植物化学信息的现有数据,并评估北方邦Caesalpinioideae区域红色名录的地位。所提供的信息将有助于制定新的药物和药品,并解决此类药用开发物种的全球保护问题。方法:目前的研究包括对现有文献的广泛和系统的回顾,对以前收集的植物标本馆标本的研究,对当地人和部落的随机访谈,实地调查,以及2016-2020年基于GeoCAT工具的评估。该研究报告称,大多数种类的Caesalpinioideae被用于治疗消化问题(约20种)和皮肤病(19种)。结果:几乎所有品种都具有抗菌和抗氧化作用。这些药理活性可归因于植物中存在各种类型的蒽醌。结论:区域保护现状显示,区域受威胁物种8种,近危物种2种。
{"title":"Ethnomedical Applications and Conservation Status of Leguminosae- Caesalpinioideae Plants in Uttar Pradesh, India.","authors":"Shivaraman Pandey,&nbsp;Lav Singh,&nbsp;Ravi Prakash Srivastava,&nbsp;Arun Kumar Kushwaha,&nbsp;Pooja Dixit,&nbsp;Gauri Saxena,&nbsp;Lal Babu Chaudhary","doi":"10.2174/1872208316666220622230215","DOIUrl":"https://doi.org/10.2174/1872208316666220622230215","url":null,"abstract":"<p><strong>Background: </strong>This review highlights the folklore, ethnomedicinal uses and conservation status of Caesalpinioideae in Uttar Pradesh (India).</p><p><strong>Aims: </strong>It aims at compiling available data on traditional medicine, biological activity, phytochemical information and assessing the regional red list status of Caesalpinioideae in Uttar Pradesh. The information provided would help in formulating new drugs and medicines and addressing global conservation issues of such medicinally exploited species.</p><p><strong>Methods: </strong>The current study included an extensive and systematic review of available literature, the study of previous collections of herbarium specimens, random interviews with locals and tribals, field surveys, and GeoCAT tool-based assessment during 2016-2020. The study reports that the majority of species of Caesalpinioideae are used for curing digestive problems (about 20 species) and skin diseases (19 species).</p><p><strong>Results: </strong>Almost all the species have antimicrobial and antioxidant properties. These pharmacological activities can be attributed to the presence of various types of anthraquinones in plants.</p><p><strong>Conclusion: </strong>The regional conservation status reveals that eight species qualified for the status of regionally threatened category while two species fall under the near threatened category.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 2","pages":"106-141"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9456567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioactive Polysaccharides from Microalgae: A Close Look at the Biomedical Applications. 微藻生物活性多糖的生物医学应用研究。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2174/1872208316666220820092643
Mariany C Depra, Rosangela R Dias, Mariana M Maroneze, Tatiele C Nascimento, Ihana A Severo, Leila Q Zepka, Eduardo Jacob-Lopes

There is a current tendency towards bioactive natural products that can be used in different areas such as food, pharmaceutical, and biomedical. In the last decades, polysaccharides have attracted increasing interest because of their potent nontoxic effects, therapeutic properties, and diversified range of applications. Polysaccharides are complex and heterogeneous macromolecules constituted of different monosaccharides and, in some cases, of glucuronic acid and sulphate groups. Polysaccharides with biological activity can be derived from plants, animals and microorganisms, especially microalgae. Microalgae are considered one of the most promising sources of these compounds that have already proved to have several important biological properties. In this sense, our objective is to elucidate the use of bioactive polysaccharides from microalgae in biomedical applications, emphasizing the biological activity of these compounds. Furthermore, the microalgal biomass production systems and polysaccharides extraction methods were presented and discussed.

目前的趋势是生物活性天然产品可用于不同领域,如食品,制药和生物医学。在过去的几十年里,多糖因其强大的无毒作用、治疗特性和广泛的应用范围而引起了人们越来越多的兴趣。多糖是由不同的单糖组成的复杂而不均匀的大分子,在某些情况下,由葡萄糖醛酸和硫酸盐基团组成。具有生物活性的多糖可以从植物、动物和微生物中提取,尤其是微藻。微藻被认为是这些化合物最有前途的来源之一,这些化合物已经被证明具有几种重要的生物学特性。从这个意义上讲,我们的目的是阐明从微藻中提取的生物活性多糖在生物医学中的应用,强调这些化合物的生物活性。此外,还对微藻生物量生产体系和多糖提取方法进行了介绍和讨论。
{"title":"Bioactive Polysaccharides from Microalgae: A Close Look at the Biomedical Applications.","authors":"Mariany C Depra,&nbsp;Rosangela R Dias,&nbsp;Mariana M Maroneze,&nbsp;Tatiele C Nascimento,&nbsp;Ihana A Severo,&nbsp;Leila Q Zepka,&nbsp;Eduardo Jacob-Lopes","doi":"10.2174/1872208316666220820092643","DOIUrl":"https://doi.org/10.2174/1872208316666220820092643","url":null,"abstract":"<p><p>There is a current tendency towards bioactive natural products that can be used in different areas such as food, pharmaceutical, and biomedical. In the last decades, polysaccharides have attracted increasing interest because of their potent nontoxic effects, therapeutic properties, and diversified range of applications. Polysaccharides are complex and heterogeneous macromolecules constituted of different monosaccharides and, in some cases, of glucuronic acid and sulphate groups. Polysaccharides with biological activity can be derived from plants, animals and microorganisms, especially microalgae. Microalgae are considered one of the most promising sources of these compounds that have already proved to have several important biological properties. In this sense, our objective is to elucidate the use of bioactive polysaccharides from microalgae in biomedical applications, emphasizing the biological activity of these compounds. Furthermore, the microalgal biomass production systems and polysaccharides extraction methods were presented and discussed.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":"17 4","pages":"296-311"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9532830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Recent patents on biotechnology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1